ISRN urology最新文献_第9页

Urachal sinus presenting with abscess formation. 尿管窦有脓肿形成。

ISRN urology Pub Date : 2011-01-01 Epub Date: 2011-04-14 DOI: 10.5402/2011/820924

Jalal Eddine El Ammari, Youness Ahallal, Oussama El Yazami Adli, Mohammed Jamal El Fassi, My Hassan Farih

引用次数: 12

Penile reconstruction for a case of genital lymphoedema secondary to proteus syndrome. 生殖器淋巴水肿继发于变形综合征1例阴茎再造术。

ISRN urology Pub Date : 2011-01-01 Epub Date: 2011-03-30 DOI: 10.5402/2011/431536

F Ashouri, J Manners, R Rees

{"title":"Penile reconstruction for a case of genital lymphoedema secondary to proteus syndrome.","authors":"F Ashouri, J Manners, R Rees","doi":"10.5402/2011/431536","DOIUrl":"https://doi.org/10.5402/2011/431536","url":null,"abstract":"To our knowledge penile lymphoedema secondary to Proteus syndrome has not previously been reported. Hence we report a case of a 16-year-old male who was referred with features of right hemi-hypertrophy and severe lymphoedema affecting his scrotum and penis. He had previously undergone scrotal reduction surgery at the age of 13, but had since developed worsening penile oedema. His main concern was that of cosmetic appearance prior to sexual debut, and he also complained of erectile dysfunction. An MRI confirmed gross oedema of the penile skin, but normal underlying cavernosal structure, and no other anatomical abnormality. Under general anaesthesia, the entire diseased penile skin was excised. Two full thickness skin grafts were harvested from the axillae, and grafted onto the dorsal and ventral penile shaft respectively. A compressive dressing and urinary catheter was applied for 7 days. Follow-up at 4 months confirmed complete graft take with minimal scarring, and the patient was very satisfied with the cosmetic outcome. He had also noticed a recovery in erectile activity, and feels psychologically and physically more prepared for sexual relations.","PeriodicalId":89401,"journal":{"name":"ISRN urology","volume":"2011 ","pages":"431536"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/431536","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30254375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Unique presentation of intra-abdominal testis: small bowel obstruction. 腹内睾丸的独特表现:小肠梗阻。

ISRN urology Pub Date : 2011-01-01 Epub Date: 2011-06-14 DOI: 10.5402/2011/579153

Ibrahim E Bassiouny, Tariq O Abbas, Amani N Alansari, Mansour A Ali

引用次数: 3

Small cell carcinoma of the renal pelvis: a case report and review of the literature. 肾盂小细胞癌1例报告及文献复习。

ISRN urology Pub Date : 2011-01-01 Epub Date: 2011-04-28 DOI: 10.5402/2011/786505

Sachin Patil, R C M Kaza, A K Kakkar, Ronald S Chamberlain

{"title":"Small cell carcinoma of the renal pelvis: a case report and review of the literature.","authors":"Sachin Patil, R C M Kaza, A K Kakkar, Ronald S Chamberlain","doi":"10.5402/2011/786505","DOIUrl":"https://doi.org/10.5402/2011/786505","url":null,"abstract":"Extrapulmonary small cell carcinoma occurs in nearly all organs except the central nervous system and the liver. We are presenting a case of renal small cell carcinoma (SCC) with two unique characters. A 75-year-old patient was evaluated for back pain with no other complaints. Magnetic Resonance (MR) imaging of the abdomen revealed homogeneous tumor in the left renal pelvis extending beyond the kidney. Metastatic workup was negative. A left nephroureterectomy was performed. Histopathology and immunohistochemistry revealed a small cell carcinoma of the renal pelvis. The patient declined adjuvant therapy and died 2 months after surgery due to unrelated causes. After comprehensive worldwide literature search, we found 13 cases of SCC of the renal pelvis, including the current case. The mean age was 61.6 years (37-83), with a M : F ratio of 1 : 1.8. The average duration of symptoms was 71.4 days (21-168). Gross hematuria was the most common symptom (69.2%) followed by pain (61.5%). Adjuvant chemotherapy was provided to 4 patients (30.7%), and neoadjuvant to 1 patient. The median survival of patients who did and did not receive chemotherapy was 5.5 months (3-8) and 6 months (2-31), respectively, P < .50. In conclusion, renal SCC (both parenchymal and pelvic SCC) is a rapidly fatal disease with a median survival of ≤8 months.","PeriodicalId":89401,"journal":{"name":"ISRN urology","volume":"2011 ","pages":"786505"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/786505","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30255381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 12

Downstaging of TURBT-Based Muscle-Invasive Bladder Cancer by Radical Cystectomy Predicts Better Survival. 通过根治性膀胱切除术降低基于turbt的肌肉浸润性膀胱癌的分期预测更好的生存率。

ISRN urology Pub Date : 2011-01-01 Epub Date: 2011-04-27 DOI: 10.5402/2011/458930

P R van Dijk, M Ploeg, K K H Aben, P C Weijerman, H F M Karthaus, J Th H van Berkel, A C Viddeleer, A Geboers, E van Boven, J A Witjes, L A L M Kiemeney

{"title":"Downstaging of TURBT-Based Muscle-Invasive Bladder Cancer by Radical Cystectomy Predicts Better Survival.","authors":"P R van Dijk, M Ploeg, K K H Aben, P C Weijerman, H F M Karthaus, J Th H van Berkel, A C Viddeleer, A Geboers, E van Boven, J A Witjes, L A L M Kiemeney","doi":"10.5402/2011/458930","DOIUrl":"https://doi.org/10.5402/2011/458930","url":null,"abstract":"Differences between clinical (cT) and pathological tumor (pT) stage occur often after radical cystectomy (RC) for muscle-invasive bladder cancer. In order to evaluate the impact of downstaging on recurrence and survival, we selected patients from a large, contemporary, population-based series of 1,409 patients with MIBC. We included all patients who underwent RC (N=643) and excluded patients who received (neo)adjuvant therapy, those with known metastasis at time of diagnosis, and those with nonurothelial cell tumors. Disease outcomes were defined as recurrence-free survival (RFS) and relative survival (RS), as a good approximation of bladder cancer-specific survival. After applying the exclusion criteria, 375 patients were eligible for analysis. Tumor downstaging was found to be common after RC; in 99 patients (26.4%), tumor downstaging to non-muscle-invasive stages at RC occurred. Hydronephrosis at baseline and positive lymph nodes at RC occurred significantly less often in these patients. In 62 patients, no tumor was left in the cystectomy specimen. pT stage was pT1 in 20 patients and pTis in 17 patients. Patients with tumor downstaging have about a 30% higher RFS and RS compared to those without. Consequently, tumor downstaging is a favorable marker for prognosis after RC.","PeriodicalId":89401,"journal":{"name":"ISRN urology","volume":"2011 ","pages":"458930"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/458930","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30254376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 20

Robotic-assisted laparoscopic prostatectomy for high-risk prostate cancer: technical considerations and review of the literature. 高危前列腺癌的机器人辅助腹腔镜前列腺切除术:技术考虑和文献综述。

ISRN urology Pub Date : 2011-01-01 Epub Date: 2011-09-25 DOI: 10.5402/2011/201408

Sean P Stroup, Christopher J Kane

引用次数: 4

Surgical Treatment of Iatrogenic Rectourinary Fistula-York-Mason Technique-a Case Report. 医源性直肠瘘的外科治疗- york - mason技术1例报告。

ISRN urology Pub Date : 2011-01-01 Epub Date: 2011-06-15 DOI: 10.5402/2011/292517

Pedro Bargão Santos, Fernando Ferrito, Rocha Pires

{"title":"Surgical Treatment of Iatrogenic Rectourinary Fistula-York-Mason Technique-a Case Report.","authors":"Pedro Bargão Santos, Fernando Ferrito, Rocha Pires","doi":"10.5402/2011/292517","DOIUrl":"https://doi.org/10.5402/2011/292517","url":null,"abstract":"Introduction. Recto-urinary fistulas resulting from trauma or surgery are a serious and debilitating complication. They represent a challenge not only because of the difficulty on choosing the best technique to solve them but also because of the risk of recurrence. Spontaneous cure is rare. Materials and Methods. We describe the case of a 61-years-old man that on the 9th postoperative day of a laparoscopic radical prostatectomy (LRP) started with fecaluria and liquid faeces. Recto-urinary fistula was confirmed at the 10th postoperative day by CT scan and contrast enema. Discussion. We chose the York-Mason technique, because it is simple to perform, effective and has minimal morbidity. This is a posterior, transrectal, and transsphincteric approach, carried out on healthy tissues without previous scarring phenomena. Results. The postoperative period progressed without complications, and the patient discharged on the 4th day. The closure of the fistula was confirmed radiologically by retrograde cystography after 4 weeks allowing the removal of drainage catheter. The reconstruction of intestinal transit was carried out 2 months later. Conclusion. The York-Mason technique, a transrectal and transsphincteric approach with minimal morbidity, proved to be effective on the resolution of the recto-urinary fistula, a rare complication of the radical prostatectomy.","PeriodicalId":89401,"journal":{"name":"ISRN urology","volume":"2011 ","pages":"292517"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/292517","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30254371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A rare case of recurrent hematuria from right kidney: radiologic diagnosis and treatment. 罕见右肾复发性血尿1例:影像学诊断与治疗。

ISRN urology Pub Date : 2011-01-01 Epub Date: 2011-07-19 DOI: 10.5402/2011/159104

Pietro Venetucci, Mario Quarantelli, Vittorio Iaccarino

引用次数: 3

Novel vitamin d analogs for prostate cancer therapy. 新型维生素d类似物用于前列腺癌治疗。

ISRN urology Pub Date : 2011-01-01 Epub Date: 2011-09-19 DOI: 10.5402/2011/301490

Tai C Chen, Atsushi Kittaka

引用次数: 21

Assessment of the effects of zoledronic Acid therapy on bone metabolic indicators in hormone-resistant prostate cancer patients with bone metastatasis. 唑来膦酸治疗对激素抵抗性前列腺癌骨转移患者骨代谢指标的影响

ISRN urology Pub Date : 2011-01-01 Epub Date: 2011-05-04 DOI: 10.5402/2011/392014

Abdullah Demirtas, Nurettin Sahin, Mehmet Caniklioglu, Mustafa Kula, Oguz Ekmekcioglu, Atila Tatlisen

{"title":"Assessment of the effects of zoledronic Acid therapy on bone metabolic indicators in hormone-resistant prostate cancer patients with bone metastatasis.","authors":"Abdullah Demirtas, Nurettin Sahin, Mehmet Caniklioglu, Mustafa Kula, Oguz Ekmekcioglu, Atila Tatlisen","doi":"10.5402/2011/392014","DOIUrl":"https://doi.org/10.5402/2011/392014","url":null,"abstract":"Purpose. Assessment of effects of zoledronic acid therapy on bone metabolic indicators in hormone-resistant prostate cancer patients with bone metastasis. Material and Methods. Hormone-resistant prostate cancer patients who were identified to have metastases in their bone scintigraphy were taken to trial group. Before administration of zoledronic acid, routine tests for serum calcium, total alkalen phosphates were studied. Sample sera for bone metabolic indicators BALP, PINP, and ICTP were collected. Bone pain was assessed via visual analogue scale and performance via Karnofsky performance scale. Four mg zoledronic acid was administered intravenously once a month. Results. When serum levels of bone forming indicators PINP; BALP were compared before and after therapy, there were insignificant decreases (P = .33, P = .21, resp.). Serum levels of bone destruction indicator ICTP was compared, and there was a significant decrease after zoledronic acid therapy (P = .04). When performances of the patients were compared during therapy period, performances decreased significantly due to progress of illness (P = .01). All patients had ostalgia caused by bone metastases at various degrees. Significant decrease in pain scores was observed (P < .01). Conclusion. Zoledronic acid therapy decreased bone destruction and was effective in palliation of pain in patient with bone metastasis. Using bone metabolic indicators during followup of zoledronic acid therapy might be useful.","PeriodicalId":89401,"journal":{"name":"ISRN urology","volume":"2011 ","pages":"392014"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/392014","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30254374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0